Skip to main content
. 2022 Oct 25;3(4):1021–1029. doi: 10.1016/j.bpsgos.2022.10.001

Table 1.

Demographic, Clinical, and Sleep Characteristics of the Participants

Characteristic Patients, n = 38
Control Subjects, n = 38
Unmedicated 7-Day Medicated
Age, Years, Mean ± SD 31.3 ± 10.2 31.6 ± 10.4
Gender Ratio, Female/Male, n 18/20 21/17
HAM-D, Mean ± SD 19.9 ± 3.8 15.2 ± 4.8
No. of Previous Depressive Episodes, Mean ± SD 1.76 ± 3.0
Sleep Stages, Minutes (%)
 N1 52.38 (12.4%) 62.53 (15.0%) 52.34 (12.4%)
 N2 186.51 (44.1%) 201.03 (48.0%) 195.11 (46.2%)
 N3 76.64 (18.4%) 70.74 (17.2%) 82.96 (19.9%)
 REM 68.93 (16.3%) 49.54 (11.8%)b,c 69.34 (16.3%)
 WASO 37.83 (8.8%)a 33.28 (8.0%)b 21.82 (5.2%)
Total Non-REM Sleep Time, Minutes (%) 263.16 (68.2%) 271.76 (70.6%) 278.07 (69.7%)
Total Sleep Time, Minutes, Mean ± SD 384.47 ± 40.0 383.83 ± 38.8 399.75 ± 39.4
Sleep Onset, Minutes, Mean ± SD 24.1 ± 30.8 20.9 ± 13.8 15.7 ± 9.6
N3 Onset, Minutes, Mean ± SD 24.91 ± 24.0 24.14 ± 19.8 18.21 ± 8.4
REM Onset, Minutes, Mean ± SD 98.61 ± 52.6 157.63 ± 79.6b,c 85.41 ± 34.8

Sleep stage percentages are given with respect to total sleep time. Non-REM sleep was defined as the combination of stages N2 and N3 without N1 sleep.

HAM-D, Hamilton Depression Rating Scale; REM, rapid eye movement; WASO, wakefulness after sleep onset.

a

Significant difference between control subjects and unmedicated patients.

b

Significant difference between control subjects and medicated patients.

c

Significant difference between the unmedicated and medicated states of the patients.